Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Market Report, "ViroPharma Incorporated - SWOT, Strategy and Corporate Finance Report", published


Print article Print article
2013-02-02 04:43:58 - Recently published research from MarketLine, "ViroPharma Incorporated - SWOT, Strategy and Corporate Finance Report", is now available at Fast Market Research

ViroPharma Incorporated - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on ViroPharma Incorporated required for business and competitor intelligence needs
* A study of the major internal and external factors affecting ViroPharma Incorporated in the form of a SWOT analysis
* An in-depth view of the business model of ViroPharma Incorporated including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for ViroPharma Incorporated
*

Intelligence on ViroPharma Incorporatednv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about ViroPharma Incorporated, such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends


Full Report Details at
- www.fastmr.com/prod/533624_viropharma_incorporated_swot_strategy ..


Highlights:

ViroPharma is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases. The company is headquartered in Exton, Pennsylvania and employed 232 people as of December 31, 2010. The company recorded revenues of $439 million during the financial year ended December 2010 (FY2010), an increase of 41.4% over FY2009. The operating profit of the company was $211.7 million during FY2010, as compared to operating profit of $32.1 million in FY2009. The net profit was $125.6 million in FY2010, as compared to net loss of $11.1 million in FY2009.
Reasons to Purchase:

* Gain understanding of ViroPharma Incorporated and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess ViroPharma Incorporated as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on ViroPharma Incorporated's business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
ViroPharma Incorporated: Company Overview
ViroPharma Incorporated: Overview and Key Facts
ViroPharma Incorporated: Overview
ViroPharma Incorporated: Key Facts
ViroPharma Incorporated: Key Employees
ViroPharma Incorporated: Key Employee Biographies
ViroPharma Incorporated: Major Products and Services
ViroPharma Incorporated: Company History
ViroPharma Incorporated: Management Statement
ViroPharma Incorporated: Locations and Subsidiaries
ViroPharma Incorporated: Key Competitors
ViroPharma Incorporated: Company Analysis
ViroPharma Incorporated: Business Description
ViroPharma Incorporated: SWOT Analysis
ViroPharma Incorporated: SWOT Overview
ViroPharma Incorporated: Strengths
ViroPharma Incorporated: Weaknesses
ViroPharma Incorporated: Opportunities
ViroPharma Incorporated: Threats
ViroPharma Incorporated: Corporate Financial Deals Activity
ViroPharma Incorporated: Financial Deals Overview
ViroPharma Incorporated: Targets and Partners
ViroPharma Incorporated: Top Deals 2008 - 2012YTD*
ViroPharma Incorporated: Advisors
ViroPharma Incorporated: Top Financial Advisors
ViroPharma Incorporated: Mergers and Acquisitions
ViroPharma Incorporated: Partnership
ViroPharma Incorporated: Recent Developments
ViroPharma Incorporated: News and Events Summary
ViroPharma Incorporated: Contracts
ViroPharma Incorporated: Financial Performance
ViroPharma Incorporated: Regulatory and Legal Events
ViroPharma Incorporated: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: ViroPharma Incorporated: Key Facts
Table 2: ViroPharma Incorporated: Key Employees
Table 4: ViroPharma Incorporated: Key Competitors
Table 5: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Table 7: ViroPharma Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: ViroPharma Incorporated: Targets and Partners
Table 9: ViroPharma Incorporated: Top Deals 2008 - 2012YTD*
Table 10: ViroPharma Incorporated: Financial Advisor Ranking by Value (US$m)
Table 11: ViroPharma Incorporated: M&A Volume and Value Trend (2008 - YTD*2012)
Table 12: ViroPharma Incorporated: M&A Activity by Geography (2008 - YTD*2012)
Table 13: ViroPharma Incorporated: Partnership Volume and Value Trend (2008 - YTD*2012)
Table 14: ViroPharma Incorporated: Partnership Trend by Deal Type (2008 - YTD*2012)
Table 15: ViroPharma Incorporated: News and Events Summary
Table 16: ViroPharma Incorporated: Contracts
Table 17: ViroPharma Incorporated: Financial Performance
Table 18: ViroPharma Incorporated: Regulatory and Legal Events
Table 19: ViroPharma Incorporated: Research & Development

List of Figures

Figure 1: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: ViroPharma Incorporated: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Figure 3: ViroPharma Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: ViroPharma Incorporated: M&A Volume and Value Trend (2008 - YTD*2012)
Figure 5: ViroPharma Incorporated: M&A Activity by Geography (2008 - YTD*2012)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=533624&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com